Results 191 to 200 of about 9,124,305 (304)
ABSTRACT Autologous cell therapy (AuCT) manufacturing networks must balance two competing objectives: reducing cost and improving patient access to time‐sensitive therapy. This study compares three AuCT manufacturing network designs: a centralized network with a single manufacturing facility, a coordinated point‐of‐care (POC) network in which POCs can ...
Zhaowei Li +3 more
wiley +1 more source
Blockchain-enabled supply chain finance risk intelligent assessment and trust mechanism construction. [PDF]
Chen Z, Zhang F.
europepmc +1 more source
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga +2 more
wiley +1 more source
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng +4 more
wiley +1 more source
Procurement architecture as a determinant of rehabilitation system performance: insights from Ukraine's prosthetics sector. [PDF]
Sullivan A, Golyk V, Quinn ME, Karpov O.
europepmc +1 more source
Kin discrimination in plants: overview and implications for population and community ecology
ABSTRACT Following the discovery of identity discrimination, particularly self and kin discrimination amongst plant competitors, research on interplant interactions has advanced significantly within plant physiology and evolutionary ecology. This review synthesizes current knowledge on how both self and kin discrimination influence plant growth ...
Akira Yamawo
wiley +1 more source
Knowing better, doing better: Taking stock of the UN Agenda 2030, its means, its progress, and its shortfalls. [PDF]
Sota R, Kammen DM, Klemun M, Venghaus S.
europepmc +1 more source
A Business Framework for Product Take‐Back—A Structured Multiple‐Case Analysis
ABSTRACT The potential of take‐back systems remains largely unrealized as initiatives have proven difficult to implement in practice. The question is why we do not see more take‐back systems given the substantial environmental benefits. We try to understand the challenges and stumbling blocks in setting up take‐back from a business perspective.
Rasmus Jørgensen, Torben Pedersen
wiley +1 more source
Smart cellular bricks for decentralized shape classification and damage recovery. [PDF]
Moreno R +4 more
europepmc +1 more source

